菜单栏
首页» Home» News» News & Events

Joint Research Results of SSDPP Printed in The Lancet Public Health

Release time:2020-12-22   views:
  



https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/atypon:cms:attachment:img:d4e6:rev:1607518533834-181:pii:S2468266720X00120/cover.tif.jpg

The joint research paper of Zhou Maigeng's research team from the Center for Chronic Non-communicable Disease Control and Prevention of the Chinese Center for Disease Control and Prevention and SSDPP's Professor Zhang Xiulan and Associate Professor Xu Xiaoxin's research team in the field of e-cigarette user behavior in China was printed in The Lancet Public Health (No.12, 2020).


This paper first introduces the current situation and trend of e-cigarette use among Chinese adults in recent years, and provides baseline data for the evaluation of China's e-cigarette sales restriction policy. According to the research, 1.3% of Chinese adults used e-cigarettes in the past 30 days from 2015 to 2016, and this proportion rose to 1.6% from 2018 to 2019. Among the e-cigarette users with a history of smoking traditional cigarettes, e-cigarette use is related to daily smoking, smoking more than 20 cigarettes per day on average and trying to quit smoking; among the e-cigarette users without a history of smoking, e-cigarette use is related to awareness of the hazards of traditional cigarettes. The authors call on China to adjust its tobacco control strategies to cope with the increasing use of e-cigarettes among young adults, obese people and e-cigarette users who are aware of the dangers of smoking but have no history of smoking traditional cigarettes.


The Lancet Public Health is a sub-journal of the authoritative medical journal Lancet family focusing on public health practice and policy-making, with an impact factor of 16.292 (2019 Journal Citation Reports, Clarivate Analytics 2020) in 2019. This is another paper themed on e-cigarette of our research team of e-cigarette regulatory policy published in the Lancet family journal after discussing China's e-cigarette regulatory policy in the Lancet Respiratory Medicine in 2016. It is also the fourth English paper of the research team in the field of e-cigarette regulatory policy published in recent years.




Full text links: https://www.thelancet.com/journals/lanpub/article/PIIS2468-2667(20)30145-6/fulltext